EGFR and inflammatory breast carcinoma: The findings of the above-described experiments, together with previous investigation of EGFR pathway in IBC tumorigenicity and metastasis [15], demonstrated that both the EGFR and COX-2 pathways regulate the EMT-like phenotype and the CSC marker-bearing population in IBC.